Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025. MBX 1416 Phase 2 trial in patients with post-bariatric ...

Monogram Orthopaedics Inc ( ($MGRM) ) has issued an update. On March 17, 2025, Monogram Technologies Inc. announced that it received FDA 510(k) ...

Monogram Technologies announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Monogram mBos TKA System. This ...

Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).

Monogram gains FDA clearance for its robotic-assisted knee surgery system and plans clinical trials in India to expand ...

Normani and D.K. Metcalf are engaged, the newly minted Pittsburgh Steeler announces. He popped the question to the R&B singer ...

MGRM READ THE FULL MGRM RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results Monogram (NASDAQ:MGRM) reported 4th ...

Q4 2024 Earnings Call Transcript March 12, 2025 Larry Holub: Good afternoon everyone. I’m Larry Holub, Director at MZ North America, and would like to welcome you to the Monogram Technologies fourth ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

At the ribbon cutting are: Parker Roop (from left) and Joe Aguilar with Patrick Building Supply; Antwain Mitchell, Andrew Payne, Eli Wood, Paul Pascale, and Instructor Philip Steagall with Patrick ...

Monogram Technologies Inc. ( NASDAQ: MGRM) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief ...

This Press Release is Acting as a Correction to the Financial Tables in the Previous ReleaseCompleted all Supplemental Testing and has Submitted ...